This study was designed to evaluate proton magnetic resonance spectroscopy (This prospective study included adult patients with progressive LGG that was confirmed by magnetic resonance imaging (MRI). Temozolomide was administered at every 28 days. Response to TMZ was evaluated by monthly MRI examinations that included MRI with volumetric calculations andA total of 21 LGGs from 31 patients were included in the study, and followed for at leastThe